MODEL VERDICT
Nanobiotix S.A. (NBTX)
Relative Valuation•Peer multiples, Monte Carlo simulation & quality-adjusted fair value
Popular:
Composite score derived from valuation, quality, and risk factors
Quantitative model thresholds · For educational and research purposes only
Each row records the model's monthly assessment. High Conviction = the model detected notable undervaluation vs peers. Neutral = no notable divergence was found. The return column shows the actual price change over 90 days for reference. This is a quantitative observation log — not investment advice.
| Date | Assessment | Score | Price | Status | 90d Fwd Return |
|---|---|---|---|---|---|
| Dec 17, 2024 | MODERATE | 0.63 | $3.54 | CURRENT | -5.4% |
| Nov 17, 2024 | MODERATE | 0.63 | $3.93 | Scaled in | +2.5% |
| Oct 18, 2024 | MODERATE | 0.63 | $4.73 | Monitoring | -37.4% |
| Sep 18, 2024 | MODERATE | 0.63 | $4.93 | Monitoring | -28.2% |
| Aug 19, 2024 | MODERATE | 0.63 | $4.91 | Monitoring | -20.0% |
Historical model observations for research purposes only. Past quantitative patterns do not predict future results. Not a recommendation to buy, sell, or hold any security.
Cross-sectional regression predicting expected multiples based on growth, margins, ROIC, and beta.
| Multiple | Avg | Median | Min | Max | Std |
|---|---|---|---|---|---|
| P/S Ratio | 2046.95 | 66.53 | 7.42 | 8047.32 | 4000.47 |
Insufficient data to determine relative valuation for NBTX.
Fair value could not be computed for NBTX due to insufficient comparable data.
NBTX's current P/E of -26.9x compares to the industry median of 24.9x (1 peers in the group). This represents a -208.0% discount to the industry. The historical average P/E is N/Ax over 0 years. Signal: Deep Discount.
3 analysts cover NBTX with a consensus rating of Buy. The consensus price target is $28.00 (range: $26.00 — $30.00), implying -38.4% upside from the current price. Grade breakdown: Strong Buy (0), Buy (2), Hold (1), Sell (0), Strong Sell (0).
The model confidence score is 43/100, based on: data completeness (0), peer quality (25), historical depth (10), earnings stability (5), and model agreement (3). Cyclicality penalty: -0 points. The model shows moderate agreement across inputs.
The model flags several key risks: (1) Macro/regulatory risks are not captured in this model but remain material.
Peak earnings risk data is not available for NBTX.
No. This dashboard is a quantitative research tool for educational and informational purposes only. It is not investment advice, a solicitation, or a recommendation to buy, sell, or hold any security. The operator of this platform is not a registered investment advisor (RIA), broker-dealer, or financial planner. All model outputs, fair value estimates, signals, and scenarios are the result of automated quantitative computations and should not be construed as professional financial guidance. You should consult a qualified, licensed financial advisor before making any investment decisions. Past model performance is not indicative of future results.